ストックスクリーナーアプリを入手
12.30
0.65%
0.08
前日終値:
$12.22
開ける：
$12.2
24時間の取引高:
1.17M
Relative Volume:
0.70
時価総額：
$781.54M
収益：
$139.91M
当期純損益:
$-140.75M
株価収益率:
-273.94
EPS:
-0.0449
ネットキャッシュフロー:
$-20.85M
1週間 パフォーマンス:
+3.10%
1か月 パフォーマンス:
+22.51%
6か月 パフォーマンス:
+35.46%
1年 パフォーマンス:
+124.04%
1日の値動き範囲:
$12.18
$12.33
1週間の範囲:
$12.02
$12.33
52週間の値動き範囲:
$4.0705
$12.48
Avid Bioservices Inc Stock (CDMO) Company Profile
CDMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| CDMO | 12.30 | 781.54M | 139.91M | -140.75M | -20.85M | -0.0449 |
| VRTX | 448.37 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 743.45 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 588.56 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.89 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.28 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Avid Bioservices Inc Stock (CDMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-28 | 開始されました | William Blair | Mkt Perform |
| 2023-03-14 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-08 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-03-17 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2019-12-10 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-17 | 開始されました | Stephens | Overweight |
| 2019-10-16 | 開始されました | Craig Hallum | Buy |
| 2019-06-28 | アップグレード | Janney | Neutral → Buy |
| 2019-05-09 | ダウングレード | Janney | Buy → Neutral |
すべてを表示
Avid Bioservices Inc (CDMO) 最新ニュース
185,120 Shares in Avid Bioservices, Inc. (NASDAQ:CDMO) Acquired by Phocas Financial Corp. - MarketBeat
Avid Bioservices' SWOT analysis: biomanufacturing stock faces acquisition, growth challenges - Investing.com Nigeria
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Royce & Associates LP - MarketBeat
Avid Bioservices, Inc. (CDMO): A Bull Case Theory - Insider Monkey
Janney Montgomery Scott LLC Buys 1,800 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
Avid Bioservices gains as holder opposes $12.50 a share takeover - MSN
Punch and Associates Sends Letter to Board of Directors of Avid Bioservices, Inc - Marketscreener.com
Punch and Associates sends letter to Board of Directors of Avid Bioservices, Inc. - Voice Of Alexandria
Significant Shareholder Brock Pond Capital Partners Sends Letter to Avid Bioservices Company Board of Directors Opposing GHO/Ampersand Transaction - Longview News-Journal
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Bought by GSA Capital Partners LLP - MarketBeat
GHO, Ampersand to take Avid Bioservices private - BioCentury
GHO Capital Partners and Ampersand Capital Partners’ $1.1 Billion Acquisition of Avid Bioservices - Global Legal Chronicle
Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand - MSN
Creative Planning Raises Stock Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc.CDMO - Business Wire
Avid Bioservices (NASDAQ:CDMO) Sees Strong Trading VolumeTime to Buy? - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, VINE, YOTA on Behalf of Shareholders - GlobeNewswire Inc.
Avid Bioservices to be taken private by GHO, Ampersand in $1.1 billion deal - MSN
Avid Bioservices Enters Agreement to Merge with Space Finco, Inc., Parent, and Merger Sub - Defense World
Avid Bioservices to Go Private in $1.1 Billion Deal - MSN
Avid Bioservices: Take-Private Deal At A Reasonable Price, Maintaining Buy (NASDAQ:CDMO) - Seeking Alpha
Private Equity Is Picking Up Biologics CDMO Avid Bioservices in $1.1B Acquisition - MSN
Avid Bioservices to be Acquired in $1.1 Billion Deal - Yahoo Finance
Shareholder Alert: Ademi LLP Investigates Whether Avid Bioservices, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Avid Bioservices, Inc. - cnhinews.com
CDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to Shareholders - Business Wire
Avid Bioservices (NASDAQ:CDMO) Shares Gap UpStill a Buy? - MarketBeat
Rx Rundown: Avid Bioservices, Novo Nordisk, Zealand Pharma and more - MM+M Online
GHO, Ampersand take Avid Bioservices private for $1.1B - Axios
CDMO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Avid Bioservices to GHO Capital Partners and Ampersand Capital Partners - ForexTV.com
Avid Bioservices Shares Rise After $1.1B Buyout Offer - MarketWatch
Avid Bioservices To Be Acquired By GHO And Ampersand - Contract Pharma
PR News | JF, ICR Healthcare Work Avid's Go-Private DealThu., Nov. 7, 2024 - O'Dwyer's PR News
Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand (NASDAQ:CDMO) - Seeking Alpha
Avid Bioservices' (CDMO) Sector Perform Rating Reaffirmed at Royal Bank of Canada - MarketBeat
William Blair Reaffirms Market Perform Rating for Avid Bioservices (NASDAQ:CDMO) - MarketBeat
Avid Bioservices to be sold to private equity firms for $1.1B - Endpoints News
GHO and Ampersand Capital to acquire Avid Bioservices - Yahoo Finance
PE to buy CDMO Avid Bioservices for $1.1 billion - BioProcess Insider
The five-year returns have been strong for Avid Bioservices (NASDAQ:CDMO) shareholders despite underlying losses increasing - Simply Wall St
$1.1B acquisition prompts RBC to downgrade avid bioservices stock By Investing.com - Investing.com UK
Avid Bioservices to go private in $1.1bn private equity deal - pharmaphorum
Hershey, Upwork And 3 Stocks To Watch Heading Into Thursday - Benzinga
Avid Bioservices to be taken private by GHO, Ampersand in $1.1 bln deal - Reuters
Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction - GlobeNewswire
(CDMO) Technical Data - Stock Traders Daily
1,448,916 Shares in Avid Bioservices, Inc. (NASDAQ:CDMO) Bought by Emerald Advisers LLC - MarketBeat
Avid Bioservices, Inc. (NASDAQ:CDMO) Receives $13.50 Average Target Price from Analysts - Defense World
Brokerages Set Avid Bioservices, Inc. (NASDAQ:CDMO) Price Target at $13.50 - MarketBeat
Avid Bioservices (NASDAQ:CDMO) Shares Cross Above 200 Day Moving AverageHere's Why - MarketBeat
Avid Bioservices' Record-breaking Quarterly Revenue Ignites Hope For 2025 - RTTNews
Avid Bioservices Inc (CDMO) 財務データ
収益
当期純利益
現金流量
EPS
Avid Bioservices Inc (CDMO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Richieri Richard A. | Chief Operations Officer |
Oct 10 '24 |
Sale |
10.05 |
2,031 |
20,412 |
37,704 |
| Richieri Richard A. | Chief Operations Officer |
Oct 10 '24 |
Sale |
10.05 |
201 |
2,020 |
7,218 |
| Kwietniak Matthew R. | Chief Commercial Officer |
Oct 10 '24 |
Sale |
10.05 |
982 |
9,869 |
25,191 |
| Green Nicholas Stewart | President & CEO |
Oct 10 '24 |
Sale |
10.05 |
17,173 |
172,589 |
226,653 |
0.42%
0.16%
大文字化:
|
ボリューム (24 時間):